Wells Fargo analysts raised the rating for Molina Healthcare (NYSE:MOH) from Underweight to Equal Weight, with a new price target of $420. The adjustment is based on a detailed scenario analysis, considering variations in base earnings, Medicaid Request for Proposals (RFP) outcomes, and the approach to capital allocation.

The analysis suggests that the market has likely accounted for some level of RFP success in Molina's stock price. Therefore, significant negative impacts would require both disappointing operational results and a lack of success in RFPs. Conversely, to achieve substantial positive movement, Molina would need to secure significant wins in RFPs. This assessment indicates that the current risk/reward profile for Molina Healthcare is considered to be well-balanced.